Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Buti

Showing results (861-870 of 1,095) with videos related to

Pageof 110
Sort By:
Digestive Diseases and Sciences|August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
Journal of Gastroenterology and Hepatology|March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis BHeng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Biomedical Reports|January 14, 2020
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE studyMelissa Bersanelli, Elisabetta Lattanzi, Nunziata D'Abbiero, et al.
American Journal of Clinical Oncology|February 22, 2021
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)Daniele Santini, Marco Stellato, Ugo De Giorgi, et al.
Transplantation Proceedings|January 3, 2006
Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virusR Bárcena, S Del Campo, G Moraleda, et al.
Gastroenterology|November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting AntiviralsJulia Dietz, Simone Susser, Johannes Vermehren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2024
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLCGiulia Mazzaschi, Cristina Marrocchio, Lucas Moron Dalla Tor, et al.
Viruses|November 24, 2022
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health DisordersHeiner Wedemeyer, Vito Di Marco, Montserrat Garcia-Retortillo, et al.
Pageof 110

Showing results (861-870 of 1,095) with videos related to

Sort By:
Pageof 110
Digestive Diseases and Sciences|August 24, 2018
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 AnalysisSang Hoon Ahn, Patrick Marcellin, Xiaoli Ma, et al.
NPJ Precision Oncology|July 2, 2026
Explainable machine learning to predict immunotherapy outcomes in metastatic renal cell carcinoma - Meet-URO 15-AI studySara Elena Rebuzzi, Vanja Miskovic, Giuseppe Fornarini, et al.
Current Oncology (Toronto, Ont.)|October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO NetworkGiuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
Journal of Gastroenterology and Hepatology|March 25, 2016
Flares during long-term entecavir therapy in chronic hepatitis BHeng Chi, Pauline Arends, Jurriën G P Reijnders, et al.
Biomedical Reports|January 14, 2020
Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE studyMelissa Bersanelli, Elisabetta Lattanzi, Nunziata D'Abbiero, et al.
American Journal of Clinical Oncology|February 22, 2021
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)Daniele Santini, Marco Stellato, Ugo De Giorgi, et al.
Transplantation Proceedings|January 3, 2006
Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virusR Bárcena, S Del Campo, G Moraleda, et al.
Gastroenterology|November 18, 2017
Patterns of Resistance-Associated Substitutions in Patients With Chronic HCV Infection Following Treatment With Direct-Acting AntiviralsJulia Dietz, Simone Susser, Johannes Vermehren, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 13, 2024
Longitudinal Blood Immune-Inflammatory and Radiomic Profiling to Decode Different Patterns of Acquired Resistance to Immunotherapy in Patients with NSCLCGiulia Mazzaschi, Cristina Marrocchio, Lucas Moron Dalla Tor, et al.
Viruses|November 24, 2022
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health DisordersHeiner Wedemeyer, Vito Di Marco, Montserrat Garcia-Retortillo, et al.
Pageof 110